This is a general term for many different types of non-Hodgkin lymphoma. It's called 'non-Hodgkin' because it's different from 'Hodgkin lymphoma'. These lymphomas are very diverse, meaning they look different and behave differently. They are all cancers of the immune system.
Every report comes from a Lived member, sent anonymously.
Have you tried Rituximab for Non-Hodgkin Lymphoma?
Non-Hodgkin lymphoma is a cancer of the lymph system, the network of lymph nodes, spleen, bone marrow and vessels that helps the body fight infection. It starts when a type of white blood cell called a lymphocyte becomes abnormal and keeps multiplying. Most cases begin in B cells, the lymphocytes that make antibodies; fewer begin in T cells or natural killer cells. The abnormal cells usually collect in lymph nodes, but they can grow in almost any part of the body, including the stomach, skin, bone marrow or brain. Non-Hodgkin lymphoma is not one disease but a family of dozens of types, and the specific type shapes almost every decision that follows. Doctors sort them into two broad groups. Indolent (slow-growing) lymphomas, such as follicular lymphoma, may cause few symptoms for years. Aggressive (fast-growing) lymphomas, such as diffuse large B-cell lymphoma, the most common type, can cause symptoms that build over weeks and need prompt treatment. Hodgkin lymphoma is a separate disease with its own treatment. The most common sign is a painless swollen lymph node in the neck, armpit or groin. Some people also have fever without an obvious cause, drenching night sweats or unexplained weight loss (together called B symptoms), as well as ongoing tiredness, itching, or pain or fullness in the chest or abdomen.
In most people, doctors cannot point to a specific cause. The risk rises with age, and it is somewhat higher in men. A weakened immune system is the clearest risk factor: this includes HIV, inherited immune disorders, autoimmune diseases such as rheumatoid arthritis or Sjögren syndrome, and the long-term immune-suppressing medicines taken after an organ transplant. Some infections are linked to particular types. Epstein-Barr virus (the virus behind mononucleosis) and human T-cell leukemia virus type 1 are tied to certain lymphomas, and long-standing Helicobacter pylori infection of the stomach can lead to a slow-growing stomach lymphoma called MALT (mucosa-associated lymphoid tissue) lymphoma. Untreated celiac disease is linked to a rare intestinal T-cell lymphoma. These are associations: most people with these conditions never develop lymphoma, and many people with lymphoma have no known risk factor.
Swollen lymph nodes and the other symptoms above often have more common causes, such as infection, so a doctor starts with a history and physical exam. If a node stays enlarged or there are other concerning signs, the key test is a biopsy: removing all or part of a lymph node (or other affected tissue) so a pathologist can examine it. Laboratory tests on the cells then identify the exact type of lymphoma, which matters as much as the stage for planning treatment. Staging shows where the lymphoma is. A PET (positron emission tomography) scan combined with a CT (computed tomography) scan is commonly used; PET uses a small amount of radioactive sugar, which fast-growing lymphoma cells take up more readily, so active areas show up brighter. Stage I means lymphoma in one lymph node area, while stage IV means it has spread widely, for example to the bone marrow or liver. Some people also need a bone marrow biopsy or, when the brain is at risk, a lumbar puncture (spinal tap). Blood tests round out the picture. They include blood counts and lactate dehydrogenase (LDH), an enzyme that tends to be higher when lymphoma is more active, as well as tests for hepatitis B, hepatitis C and HIV. Hepatitis B testing matters because some lymphoma treatments, including rituximab, can reawaken a dormant hepatitis B infection, so people with past infection are monitored during and after treatment.
Treatment depends mainly on the type of lymphoma, its stage, symptoms and the person's overall health, and it is usually led by a hematologist or oncologist experienced with lymphoma. For slow-growing lymphomas that are not causing symptoms, watchful waiting (regular check-ups and scans without treatment) is often the recommended approach. This spares people the side effects of treatment until the lymphoma starts causing problems. When treatment is needed, options include radiation for disease limited to one area, or rituximab (Rituxan), a lab-made antibody that targets a marker on B cells, given alone or with chemotherapy. These lymphomas often respond well and can stay controlled for years, but they tend to return, so many people have several rounds of treatment over time. Aggressive lymphomas are usually treated soon after diagnosis with the aim of cure. For diffuse large B-cell lymphoma, the standard first treatment is R-CHOP: rituximab plus a combination of chemotherapy drugs and the steroid prednisone, given as infusions in cycles about three weeks apart, usually for three to six cycles. A newer combination built on the same backbone is an option for some people with more advanced disease. Radiation is sometimes added for a large or localized tumor. Some types have their own approach. A stomach MALT lymphoma caused by Helicobacter pylori is often treated first with antibiotics alone. If lymphoma does not respond or comes back, options include different chemotherapy, a stem cell transplant (high-dose chemotherapy followed by an infusion of blood-forming stem cells), targeted pills for certain types, and newer immune therapies. CAR T-cell (chimeric antigen receptor T-cell) therapy, in which a person's own immune cells are modified in a lab to attack the lymphoma, is used for large B-cell lymphoma that has not responded to earlier treatment and is given at specialized centers. Clinical trials are a standard option at many points.
The outlook varies more by type than for most cancers. Across all types in the United States, about three in four people are alive five years after diagnosis, and the figure is higher for early-stage disease. Diffuse large B-cell lymphoma, despite growing quickly, is cured in roughly half of people, with better results at earlier stages. Slow-growing lymphomas usually cannot be cured with standard treatment, but many people live with them for many years, often with long stretches between treatments. Occasionally a slow-growing lymphoma changes into a faster-growing type, which is one reason for regular follow-up. During treatment, tiredness and a higher risk of infection are common with chemotherapy, and many people continue some work and daily routines with adjustments. Treatment lasts a few months for many aggressive lymphomas, while people on watchful waiting may go months or years with only appointments and scans, which some find reassuring and others find unsettling. After treatment, follow-up visits check for return of the lymphoma and for late effects, problems that can appear months or years later, such as heart problems, nerve damage, infertility or a second cancer. Anyone hoping to have children should ask about fertility preservation before treatment begins. Support from lymphoma organizations, counseling and survivorship clinics can help with the emotional and practical load.
See a doctor about a lymph node that stays swollen for more than a few weeks or keeps growing, or about unexplained fevers, drenching night sweats, weight loss or persistent fatigue. If you have already been treated, report new lumps or the return of these symptoms at your next contact rather than waiting for a scheduled scan. During treatment, call your care team right away, at any hour, if you have a fever of 100.5°F (38°C) or higher, shaking chills or other signs of infection, because chemotherapy can leave the body with few infection-fighting cells. Do not take fever-lowering medicine first unless your team has told you to, since it can hide the fever. Get emergency care for new swelling of the face, neck or arms together with trouble breathing, which can mean a lymphoma in the chest is pressing on a major vein.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Non-Hodgkin Lymphoma is like, what's helped you, or ask the community a question.